AVSOLA FDA approval date

The FDA approved AVSOLA on 6 Dec 2019.

FDA approval date
6 Dec 2019

Drug identity has not yet been verified against registry records

Also recorded as INFLIXIMAB-AXXQ

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-12-06DayAVSOLAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761086", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["AVSOLA"], "active_ingredients": ["INFLIXIMAB-AXXQ"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20191206", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026